Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We investigate how innate immune sensing pathways in macrophages control tissue inflammation.

Introduction: 

Inflammation is essential for host defence and tissue repair, but when uncontrolled it becomes a major driver of chronic disease, including arthritis, neurodegeneration, cardiovascular disease, and cancer.

Our research investigates how macrophages use inflammasomes, inflammatory cell death, and intercellular communication to sense tissue damage and shape sterile inflammation.

Macrophages are central to this process because they integrate signals from tissue damage, inflammatory mediators, and the local microenvironment to determine the magnitude, quality, and duration of inflammatory responses. Using molecular, cellular, and in vivo approaches, we investigate the mechanisms that enable macrophages to sense tissue perturbation and coordinate inflammatory responses within tissues.

Major research objectives

1. Inflammasomes and inflammatory cell death in sterile inflammation.

Inflammasomes are key innate immune sensors, highly expressed in macrophages, that detect cellular stress and tissue damage. Their activation promotes the release of inflammatory cytokines and triggers inflammatory cell death pathways that profoundly influence tissue inflammation.

A major focus of our laboratory is understanding how inflammasome activity and inflammatory cell death are regulated within tissues, and how these pathways interact with the tissue inflammatory environment. We are particularly interested in the NLRP3 inflammasome, a central driver of chronic inflammatory and age-associated diseases.

In parallel, we investigate the immunological consequences of lytic cell death and how signals released from dying cells shape inflammation, tissue homeostasis, and disease.

By defining the mechanisms that regulate inflammasome activity and inflammatory cell death, we aim to uncover fundamental principles governing chronic inflammation and identify new therapeutic opportunities.

2. Intercellular Communication in Tissue Inflammation

Inflammatory responses require coordinated communication between immune cells and surrounding tissues. However, many of the mechanisms that organise inflammation at the tissue level remain poorly understood.

We investigate how macrophages transmit inflammatory information to neighbouring cells, including through CALHM6-dependent ATP signalling and other emerging pathways of intercellular communication.

Our goal is to understand how inflammatory signals propagate through tissues and how communication networks regulate the initiation, amplification, and resolution of inflammation.

 

 

 



Selected publications

The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death.

Journal article

Jones Evans EL. et al, (2026), Sci Immunol, 11

Inflammasomes as regulators of mechano-immunity.

Journal article

Bezbradica JS. and Bryant CE., (2024), EMBO Rep, 25, 21 - 30

TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activation.

Journal article

Fischer FA. et al, (2021), Proc Natl Acad Sci U S A, 118

Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity.

Journal article

Boucher D. et al, (2018), J Exp Med, 215, 827 - 840

Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals.

Journal article

Bezbradica JS. et al, (2017), Cell Mol Immunol, 14, 118 - 126

le for the ITAM signaling module in specifying cytokine-receptor functions.

Journal article

Bezbradica JS. et al, (2014), Nat Immunol, 15, 333 - 342

Integration of cytokine and heterologous receptor signaling pathways.

Journal article

Bezbradica JS. and Medzhitov R., (2009), Nat Immunol, 10, 333 - 339

Related research themes